Clinical Trial Update: Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) [Phase 2]

View source ↗

Summary

The document provides a Phase 2 clinical trial update on the efficacy and safety of slow-release DHEA for asthma, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Slow-release Dehydroepiandrosterone (DHEA) (dehydroepiandrosterone)

Snippet

Sponsor: Indiana University | Conditions: Asthma | Phase 2 | Status: NOT_YET_RECRUITING